[1] |
CHO N H,KIRIGIA J,MBANYA J C,et al.IDF diabetes atlas-9th edition 2019[N].International Diabetes Federation,2019.
|
[2] |
GONZALEZ L L,GARRIE K,TURNER M D.Type 2 diabetes-An autoinflammatory disease driven by metabolic stress[J]. Biochim Biophys Acta Mol Basis Dis,2018,1864(11):3805-3823.
|
[3] |
LECHNER A,SCHLÖßER H A,THELEN M,et al.Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma[J].Oncoimmunology,2019,8(3):1535293.
|
[4] |
KIM K,CHUNG M H,PARK S,et al.ER stress attenuation by Aloe-derived polysaccharides in the protection of pancreatic β-cells from free fatty acid-induced lipotoxicity[J].Biochem Biophys Res Commun,2018,500(3):797-803.
|
[5] |
KIRIYAMA Y,NOCHI H.Role and cytotoxicity of amylin and protection of pancreatic islet β-cells from amylin cytotoxicity[J]. Cells,2018,7(8):95.
|
[6] |
DENROCHE H C,VERCHERE C B.IAPP and type 1 diabetes:implications for immunity,metabolism and islet transplants[J].J Mol Endocrinol,2018,60(2):R57-R75.
|
[7] |
FARIDI A,SUN Y X,MORTIMER M,et al.Graphene quantum dots rescue protein dysregulation of pancreatic β-cells exposed to human islet amyloid polypeptide[J].Nano Res,2019,12(11):2827-2834.
|
[8] |
MOULLÉ V S,GHISLAIN J,POITOUT V.Nutrient regulation of pancreatic β-cell proliferation[J].Biochimie,2017,143:10-17.
|
[9] |
SAMUEL V T,SHULMAN G I.The pathogenesis of insulin resistance:integrating signaling pathways and substrate flux[J].J Clin Invest,2016,126(1):12.
|
[10] |
JASTROCH M,USSAR S,KEIPERT S.Gut microbes controlling blood sugar:no fire required[J].Cell Metab,2020,31(3):443-444.
|
[11] |
HARADA N,INAGAKI N.Role of GIP receptor signaling in β-cell survival[J].Diabetol Int,2017,8(2):137-138.
|
[12] |
EHSES J A,CASILLA V R,TIM D,et al.Glucose-dependent insulinotropic polypeptide promotes β-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase[J]. Endocri-nology, 2003,144(10):4433-4445.
|
[13] |
EL K,CAMPBELL J E.The role of GIP in α-cells and glucagon secretion[J].Peptides,2020,125:170213.
|
[14] |
JØRGENSEN M B,IDORN T,RYDAHL C,et al.Effect of the Incretin hormones on the endocrine pancreas in end-stage renal disease[J].J Clin Endocrinol Metab,2020,105(3):e564-e574.
|
[15] |
NAUCK M A,MEIER J J.Incretin hormones:their role in health and disease[J].Diabetes Obes Metab,2018,20(S1):5-21.
|
[16] |
GRANDL G,NOVIKOFF A,DIMARCHI R,et al.Gut Peptide Agonism in the treatment of obesity and diabetes[J].Compr Physiol, 2019, 10(1):99-124.
|
[17] |
DOGGRELL S A.Sgemaglutide in type 2 diabetes-is it the best glucagon-like peptide 1 receptor agonist (GLP-1R agonist)?[J]. Expert Opin Drug Metab Toxicol,2018,14(3):371-377.
|
[18] |
ROSE F,BLOOM S,TAN T.Novel approaches to anti-obesity drug discovery with gut hormones over the past 10 years[J].Expert Opin Drug Discov,2019,14(11):1151-1159.
|
[19] |
NAUCK M A,BALLER B,MEIER J J.Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes[J].Diabetes,2004,53(S3):S190-S196.
|
[20] |
GASBJERG L S,HELSTED M M,HARTMANN B,et al.Separate and combined Glucometabolic effects of endogenous glucose-dependent Insulinotropic polypeptide and glucagon-like peptide 1 in healthy indivi-duals[J].Diabetes,2019,68(5):906-917.
|
[21] |
IRWIN N,GAULT V A,O'HARTE F P M,et al.Blockade of Gastric Inhibitory Polypeptide (GIP) action as a novel means of countering insulin resis-tance in the treatment of obesity-diabetes[J].Peptides,2020,125(19):170203.
|
[22] |
YABE D,SEINO Y.Two incretin hormones GLP-1 and GIP:comparison of their actions in insulin secretion and β cell preservation[J]. Prog Biophys Mol Biol,2011,107(2):248-256.
|
[23] |
REGAZZO D,BARBOT M,SCARONI C,et al.The pathogenic role of the GIP/GIPR axis in human endocrine tumors:emerging clinical mechanisms beyond diabetes[J].Rev Endocr Metab Disord,2020,21(1):165-183.
|
[24] |
CEPERUELO-MALLAFRÉ V,DURAN X,PACHÓN G,et al.Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance[J].J Clin Endocrinol Metab,2014,99(5):E908-E919.
|
[25] |
雷雨欣,焦凯,赵国宏,等.胰岛素对β细胞FoxO1胞质-胞核穿梭定位的影响[J].现代生物医学进展,2015, 15(29):5621-5623,5644.LEI Y X,JIAO K,ZHAO G H,et al.Effect of insulin on FoxO1 nucleus-cytoplasmic shuttling in β cells[J].Progress in Modern Biomedicine,2015,15(29):5621-5623,5644.(in Chinese)
|
[26] |
KIM S J K,WINTER K,NIAN C,et al.Glucose-Dependent Insulinotropic Polypeptide (GIP) stimulation of pancreatic β-cell survival is dependent upon phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B (PKB) signaling,inactivation of the forkhead transcription factor Foxo1,and down-regulation of bax Expression[J].J Biol Chem,2005,280(23):22297-22307.
|
[27] |
CHANDRA M,MIRIYALA S,PANCHATCHARAM M.PPARγ and its role in cardiovascular diseases[J].PPAR Res,2017, 2017:6404638.
|
[28] |
刘烨,张琳,洪天配.2011年糖尿病学领域的研究进展和热点回顾[J].中国医学前沿杂志(电子版),2011,3(6):27-31.LIU Y,ZHANG L,HONG T P.Review of research progress and hot spots in the field of diabetes in 2011[J].Chinese Journal of the Frontiers of Medical Science (Electronic Version),2011,3(6):27-31.(in Chinese)
|
[29] |
KLEINERT M,CLEMMENSEN C,HOFMANN S M,et al.Animal models of obesity and diabetes mellitus[J].Nat Rev Endocrinol, 2018,14(3):140-162.
|
[30] |
CROPANO C,SANTORO N,GROOP L,et al.The rs7903146 variant in the TCF7L2 gene increases the risk of Prediabetes/Type 2 diabetes in obese adolescents by impairing β-cell function and hepatic insulin sensitivity[J].Diabetes Care,2017,40(8):1082-1089.
|
[31] |
XIA Q H X,DELIARD S,YUAN C X,et al.Characterization of the transcriptional machinery bound across the widely presumed type 2 diabetes causal variant,rs7903146,within TCF7L2[J].Eur J Hum Genet,2014,23(1):103-109.
|
[32] |
YE D,FEI Y,LING Q,et al.Polymorphisms in TCF7L2 gene are associated with gestational diabetes mellitus in Chinese Han population[J].Sci Rep,2016,6(1):30686.
|
[33] |
DA SILVA XAVIER G,MONDRAGON A,SUN G,et al.Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2 -null mice[J].Diabetologia,2012,55(10):2667-2676.
|
[34] |
孙晓阳,丁涟沭,金孝东,等.PI3K/Akt/mTOR信号传导通路与人脑胶质瘤恶性进展及预后的相关研究[J].中华神经医学杂志,2011,10(1):24-28.SUN X Y,DING L S,JIN X D,et al.Correlation of PI3K/Akt/mTOR signal transduction pathway with both malignancy progression and prognosis of human gliomas[J].Chinese Journal of Neuromedicine,2011,10(1):24-28.(in Chinese)
|
[35] |
常盛.PI3K/Akt信号通路与胰岛素抵抗的研究进展[J].中医药导报,2008,14(7):113-116.CHANG S.Progress in studying the relationship between PI3K/Akt signal access and insulin resis-tance[J].Guiding Journal of Traditional Chinese Medicine and Pharmacy,2008,14(7):113-116.(in Chinese)
|
[36] |
王帅,金磊,海春旭,等.PI3K/Akt信号通路在胰岛素抵抗中作用的研究进展[J].毒理学杂志,2015,29(4):313-316.WANG S,JIN L,HAI C X,et al.Progress on the role of PI3K/Akt signaling pathway in insulin resistance[J].Journal of Toxicology,2015,29(4):313-316.(in Chinese)
|
[37] |
GUPTA D,LEAHY A A,MONGA N,et al.Peroxisome proliferator-activated receptor γ (PPARγ) and its target genes are downstream effectors of FoxO1 protein in islet β-cells:mechanism of β-cell compensation and failure[J].J Biol Chem,2013, 288(35):25440-25449.
|
[38] |
MO F F,LIU H X,ZHANG Y,et al.Anti-diabetic effect of loganin by inhibiting FOXO1 nuclear translocation via PI3K/Akt signaling pathway in INS-1 cell[J].Iran J Basic Med Sci,2019,22(3):262-266.
|
[39] |
SHU L,SAUTER N S,SCHULTHESS F T,et al.Transcription factor 7-like 2 regulates β-cell survival and function in human pancreatic islets[J].Diabetes,2008,57(3):645-653.
|
[40] |
SHU L,MATVEYENKO A V,KERR-CONTE J,et al.Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP-and GLP-1 receptors and impaired beta-cell function[J].Hum Mol Genet,2009,18(13):2388-2399.
|
[41] |
SVEGLIATI-BARONI G,SACCOMANNO S,RYCHLICKI C,et al.Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis[J].Liver Int,2011,31(9):1285-1297.
|